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CoccidiosisDrug resistance is a problem wherever livestock are raised under intensive conditions and drugs are used
to combat parasitic infections. This is particularly true for the anticoccidial agents used for the prevention
of coccidiosis caused by protozoa of the apicomplexan genus Eimeria in poultry. Resistance has been doc-
umented for all the dozen or so drugs approved for use in chickens and varying levels of resistance is
present for those currently employed. A possible solution may be the introduction of drug-sensitive par-
asites into the houses where poultry are raised so that they may replace such drug-resistant organisms.
This can be achieved by utilizing live vaccines that contain strains of Eimeria that were isolated before
most anticoccidial compounds were introduced. Such strains are inherently drug-sensitive. Practical pro-
posals to achieve this objective involve the alternation of vaccination with medication (known as rotation
programs) in successive ﬂocks reared in the same poultry house. A proposal for a yearly broiler produc-
tion cycle involving chemotherapy and vaccination is presented. There are few, if any, examples in vet-
erinary parasitology where it has proved possible to restore sensitivity to drugs used to control a
widespread parasite. Further research is necessary to ascertain whether this can result in sustainable
and long-term control of Eimeria infections in poultry.
 2014 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Modern poultry production frequently involves the raising of
large numbers of birds on built-up litter at high stocking densities
in houses speciﬁcally designed for that purpose (Bell and Weaver,
2002). Thus, a typical broiler house may contain as many as
20–50,000 chickens reared beneath one roof at a stocking density
of one bird per 0.08 m2. Production is usually based upon the ‘‘all
in–all out’’ principle in which birds are placed on litter upon arrival
from the hatchery, remain in the house for the duration of the rear-
ing period, and then are removed either for slaughter (broilers) or
transferred to cages (some egg layers). After a brief period of a few
weeks, known as the ‘‘down-time’’ a fresh ﬂock is introduced. The
litter may be replaced after every ﬂock or after several successive
ﬂocks, in the USA it is common for six ﬂocks to be raised each year
with no change of litter. Thus, for the period of production, the
ﬂock represents a closed population. This has important implica-
tions for those organisms that parasitize poultry and the develop-
ment of preventive control strategies.Rearing birds under intensive conditions upon litter provides an
ideal opportunity for parasite transmission, especially those such
as Eimeria that develop in the intestinal tract, and have an oral/fae-
cal life cycle. Without an effective means of control the numbers of
parasites present in a house can increase to such an extent that
they can cause coccidiosis. Clinical disease is uncommon but poor
performance, manifest by reduced feed intake, poor weight gain,
and impaired feed conversion results in losses to the poultry indus-
try of many millions of dollars per annum (Williams, 1999).
2. Life cycle and genetics of Eimeria
The life cycle of a typical Eimeria species involves three phases:
(1) sporogony or sporulation – resulting in the formation of the
infective transmission stage the sporulated oocyst, (2) schizogony
– a process of asexual reproduction also known as merogony that
results in ampliﬁcation of parasite numbers in the intestine, and
(3) gametogony – the production of male and female gametes
which, following fertilization to form a zygote, becomes the
unsporulated oocyst. Sporulation involves a meiotic division fol-
lowed by a mitotic division that results in the formation of four
sporocysts; a mitotic division then occurs within each sporocyst
to form two genetically identical haploid sporozoites (Canning
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stages in the life cycle after the meiotic division in the oocyst are
haploid, thus mitotic division occurring within each schizont
results in the formation of haploid merozoites which are all genet-
ically identical and therefore represents a clonal population.
Genetic homogeneity is also more probable because there is a real
possibility of self-fertilization following gametogony, which will
result in clonal offspring (Shirley and Millard, 1976; Walker
et al., 2013). Furthermore if less than the eight sporozoites in an
ingested oocyst fail to infect the chicken, the likelihood of geneti-
cally identical gametes increases.
Several genetic traits have been identiﬁed within species of
avian coccidia, including developmental rate, enzyme variation,
antigenicity, and drug sensitivity (Jeffers, 1978). Drug resistance
in ﬁeld populations of Eimeria is widespread and generally reﬂects
the previous use of anticoccidials in the respective poultry facility
(Jeffers, 1974a,b,c). Genetic recombination between strains resis-
tant to drugs with different modes of action has been demon-
strated (e.g. Joyner and Norton, 1975; Chapman, 1984) and it has
also proved possible to obtain recombination between drug-
sensitive vaccine strains and drug-resistant strains (Jeffers,
1976b; Shirley and Harvey, 2000). This may contribute to a reduc-
tion in drug resistance (Williams, 1998, 2002a). However, the
impact of coccidiosis vaccines in restoring drug sensitivity to be
described is largely due to replacement of the resident population
of coccidia by vaccine-derived drug-sensitive coccidia, because the
rate of genetic recombination in avian coccidia is likely quite low.
For example, recombinant coccidia constituted no more than 0.04%
of the total oocysts produced in a cross between drug-sensitive and
drug-resistant strains of Eimeria tenella (Jeffers, 1974d). Although a
greater degree of hybridization was found in a cross of two drug-
resistant strains of E. tenella, the recombinant coccidia still only
comprised 1.5% of the total oocysts produced. Other studies sup-
port the notion that the rate of genetic recombination in avian coc-
cidia is apparently quite low relative to the number of parental
type coccidia produced in crosses of strains expressing different
genetic traits (see review by Chapman et al. (2013)).3. Chemotherapy and drug resistance
Anticoccidial drugs have been used in broilers for the preven-
tion of coccidiosis for many years, and today, in many countries
with large poultry industries (e.g. Brazil, China, and the USA) they
remain the mainstay of poultry production and are likely to con-
tinue to do so in the foreseeable future. Thus in a survey conducted
in the USA from 1995 to 1999 it was found that the use of drugs
was almost universal, anticoccidials being employed by 99% of
commercial broiler operations (Chapman, 2001). An analysis for
2013/2014 indicated that drug use in the USA varied from 60 to
99% depending upon the time of year (Chapman, unpublished
observations). A consequence of this extensive drug use has been
the development of resistance, which has been documented for
all drugs and wherever poultry are reared under intensive condi-
tions (Chapman, 1997).
Anticoccidial drugs can be broadly divided into two categories:
the ionophores that are produced by fermentation and the syn-
thetic drugs that are produced by chemical synthesis. Ionophores
include lasalocid, monensin, narasin, salinomycin, and semduram-
icin and are thought to have a common mode of action involving
disruption of ion gradients across the parasite cell membrane
(Chapman, 1997). Synthetic drugs include a diverse range of com-
pounds with various modes of action including inhibition of para-
site mitochondrial respiration (decoquinate, clopidol) inhibition of
the folic acid pathway (sulphonamides), and competitive inhibi-
tion of thiamine uptake (amprolium). In many cases (e.g. diclazuril,halofuginone, nicarbazin, and robenidine) the mode of action is not
known. A combination of a synthetic drug (nicarbazin) and an ion-
ophore (narasin) is also widely used in poultry production and in
the past a combination of methyl benzoquate and clopidol was
employed.
One approach adopted by the poultry industry to ameliorate
resistance has been to alternate the use of compounds with differ-
ent modes of action. This can take several forms such as the so-
called ‘‘shuttle’’ program in which different drugs are incorporated
in different feeds provided to birds. Often a synthetic drug such as
nicarbazin will be incorporated in the ﬁrst (starter) feed followed
by an ionophore in the second (grower) feed. Another approach
is the so called ‘‘rotation’’ program in which drugs with different
modes of action are employed in successive ﬂocks (McDougald,
1982). An underlying philosophy behind these programs is that if
resistance is selected during use of the ﬁrst drug then it will be lost
during use of the second but this remains unproven. Although
shuttle and rotation programs may have slowed the acquisition
of resistance, most ﬁeld isolates of Eimeria show varying levels of
resistance to more than one drug (Chapman, 1997; Peek and
Landman, 2003).4. Vaccination
Most commercially available anticoccidial vaccines contain live
oocysts of attenuated or non-attenuated strains of coccidia (Shirley
et al., 2007) but until recently their use was limited to birds reared
for egg production. They may be administered in the drinking
water or sprayed on the feed at the farm but this is labour intensive
and expensive, improved methods of administration, such as spray
cabinets in the hatchery, have facilitated their use in broiler chick-
ens (Chapman, 2000; Williams, 2002a). Low numbers of oocysts
are included in live vaccines and it may seem surprising that they
could have a signiﬁcant impact on the population of coccidia
already present in a poultry production facility. However, experi-
ments have shown that as few as 10 oocysts (of E. tenella) ingested
by a chicken may give rise to more than 500,000 oocysts as prog-
eny (Chapman, 1978). Although administration of coccidiosis vac-
cines by a spray cabinet in the hatchery does not assure that every
chick actually ingests oocysts, most birds probably do ingest them
either by preening, or by receiving oocysts in the eye, whereby it is
thought that they pass through the lacrimal duct into the nasal
cavity and thereby reach the intestine through the pharynx
(Chapman et al., 2002). Therefore, if it is conservatively assumed
that only 50% of the chicks ingest 10 or more oocysts as a result
of spray cabinet administration, 50,000 vaccinated birds could pro-
duce more than one billion new drug-sensitive vaccine-derived
oocysts when placed in a broiler production facility.
Some vaccines (e.g. Coccivac and Paracox) contain species
that were isolated before most anticoccidial drugs were introduced
and are inherently sensitive to them. Their seed stocks have subse-
quently been maintained in the laboratory for many years free of
exposure to medication. Thus, the coccidia in these vaccines are
thought to be genetically sensitive to all anticoccidials and there
is a high probability that their progeny will be drug-sensitive as
well.
Freshly passed vaccine derived oocysts are likely more infective
than older resident coccidia, thus producing many more vaccine-
derived drug-sensitive parasites following their ingestion from
the litter. This will increase the drug sensitivity of the population
of coccidia within the poultry facility. This supposition is sup-
ported by the observation that in a mixed population consisting
of drug-resistant and drug-sensitive coccidia, the drug-sensitive
parasites dominate in the absence of medication needed to confer
a selective advantage to the drug-resistant population (Long et al.,
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drug by the use of coccidiosis vaccines, it is important that medica-
tion be avoided for a period sufﬁcient to allow recycling of vaccine-
derived oocysts from the litter. As birds continue to consume albeit
small numbers of vaccine derived oocysts their immunity to subse-
quent coccidial infection increases, further negating the build-up of
the resident drug-resistant population of coccidia.5. Restoration of drug sensitivity
The pattern of drug sensitivity in a population of coccidia can be
greatly altered by the introduction of drug-sensitive coccidia,
which can be accomplished through the use of some coccidiosis
vaccines, or by the use of drug-sensitive laboratory maintained
lines (Jeffers, 1976a). In a laboratory experiment, Ball (1966)
showed that when a small number of oocysts (of E. tenella) from
a drug-resistant population were included in a larger number of
drug-sensitive parasites and propagated in unmedicated chickens,
the number of drug-resistant parasites decreased. A similar loss of
resistance to amprolium by admixture of sensitive and resistant
strains was shown by McLoughlin and Chute (1979). Restoration
of sensitivity to monensin through the use of a non-attenuated
coccidiosis vaccine was demonstrated in commercial broiler pro-
duction (Chapman, 1994) the vaccine employed (Coccivac-B)
was ﬁrst introduced in 1952 and the component strains have been
propagated in the laboratory ever since (Williams, 2002b). An
increase in the sensitivity of ﬁeld strains of Eimeria to diclazuril
and salinomycin was shown following use of the same vaccine
(Mathis and Broussard, 2006; Jenkins et al., 2010). It might be
thought that use of a vaccine containing attenuated parasites
was less likely to result in replacement of drug-resistant strains
since the parasites in such vaccines have an inherently poor repro-
ductive potential (Jeffers, 1975; Shirley, 1989). However, partial
restoration of sensitivity to diclazuril and monensin was observed
following use of the attenuated vaccine Paracox (Peek and
Landman, 2006). Restoration of sensitivity by introduction of
drug-sensitive coccidia is not conﬁned to parasites of the chicken
but also been shown in the turkey (Mathis and McDougald, 1989).
Based upon these ﬁndings, a yearly rotation program for chick-
ens involving the use of both anticoccidial chemotherapy andFig. 1. Proposal for a yearly chicken production cycle involving six successive ﬂocks
of broilers. Chemotherapy comprises an anticoccidial program involving synthetic
drugs, ionophores, or a potentiated ionophore (see text). Litter is removed (clean-
out) after the second ﬂock. The Figure is based upon an illustration by Chapman,
H.D. in Poultry Health Today.com, 2014.vaccination was proposed (Chapman et al., 2002, 2010). A variation
of such a program based upon a yearly cycle involving six
successive ﬂocks of broilers is shown in Fig. 1. For the ﬁrst two
ﬂocks (January to April), an anticoccidial chemotherapy program
is employed. This could involve a full ionophore program (iono-
phore in both starter and grower feed), a shuttle program involving
either a synthetic drug or ionophore in the starter feed and a differ-
ent ionophore in the grower feed, or the use of a potentiated ion-
ophore such as a combination of nicarbazin and narasin. This is
followed by a clean-out, or in-house composting of litter, in order
to greatly reduce the resident population of coccidia prior to place-
ment of the next ﬂock of birds. A vaccine based upon sensitive
strains may then be used for two ﬂocks (May to August) to repop-
ulate the house with the drug-sensitive strains. It is then proposed
that for the ﬁnal two ﬂocks (September to December) a different
anticoccidial program be employed with the hope that the efﬁcacy
of the latter will be improved. Programs such as this are employed
by approximately 35–40% of broiler companies in the USA (Brous-
sard, personal communication). The rotation program described is
designed for the broiler industry in the USA but many variations
may be appropriate for different production systems in other parts
of the world.
6. Conclusions
The control of avian coccidiosis is one of the major success sto-
ries of veterinary parasitology. However, as long as birds are reared
in contact with their faeces, as when they are raised on built-up lit-
ter, then diseases such as coccidiosis will continue to occur. Alter-
native production systems might limit such contact, such as the
raising of birds on wire ﬂoors, but such systems have proved to
be uneconomic in broiler production. Attempts to eradicate the
parasite by quarantine, disinfection, and sanitation have not been
successful (McDougald, 2008). Vaccination is often promoted as
an alternative to chemotherapy for the control of coccidiosis and
indeed is the method of choice for the prevention of the disease
in egg-laying stock. However, most current commercial vaccines
comprise live oocysts of several species of Eimeria that are expen-
sive and difﬁcult to produce and it is unlikely that they could be
generated in sufﬁcient quantity to satisfy the needs of the much
larger broiler industry. Coccidiosis vaccines may have a signiﬁcant
impact on the resident drug-resistant population of coccidia in
poultry facilities and play an important role in integrated control
programs involving chemotherapy and vaccination. By this means,
long-term, sustainable control of coccidiosis may be achieved.
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